STOCK TITAN

Fastenal (NASDAQ: FAST) EVP sells 9,258 shares at about $51.4

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

FASTENAL CO executive Donnalee Kathleen Papenfuss, EVP-Strategy and Communication, reported option exercises and related share sales. She exercised employee stock options covering 1,364 shares at $13.75 and 7,894 shares at $19.00 per share, receiving equivalent amounts of common stock. On the same date, she reported selling 1,364 shares at $51.4165 and 7,894 shares at $51.3841 per share. An additional 811 shares are held indirectly in a 401(K) Plan, including 345 shares acquired in that account since the prior report. Footnotes state the options vest over multi‑year schedules and that one grant’s amounts were adjusted for a 2-for-1 stock split effective May 21, 2025.

Positive

  • None.

Negative

  • None.
Insider Papenfuss Donnalee Kathleen
Role EVP-Strategy and Communication
Sold 9,258 shs ($476K)
Approx. gross sale proceeds $476K
Approx. exercise cost $169K
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) F2 1,364 $0.00 $0.00
Exercise Employee Stock Option (Right to Buy) F3, F4 7,894 $0.00 $0.00
Exercise Common Stock 1,364 $13.75 $19K
Sale Common Stock 1,364 $51.4165 $70K
Exercise Common Stock 7,894 $19.00 $150K
Sale Common Stock 7,894 $51.3841 $406K
holding Common Stock F1 -- -- --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 0 shares (Direct); Common Stock — 811 shares (Indirect, Held in 401(K) Plan)
Footnotes (4)
  1. F1. Shares attributed to reporting person's account within issuer's 401(K) Plan and includes an additional 345 shares acquired in the account since the last report on 6/9/2025.
  2. F2. The option will vest and become exercisable over a period of eight years, with 25% of the option vesting and becoming exercisable two years after the relevant vesting period, and the remainder vesting and becoming exercisable proportionately each year thereafter.
  3. F3. The option was previously reported in a Form 3 filing on 11/6/2024 and the amounts reported on this Form 4 are adjusted to reflect a 2-for-1 stock split on May 21, 2025.
  4. F4. The option will vest and become exercisable over a period of five years, with 40% of the option vesting and becoming exercisable two years following the date of grant, and the remainder vesting and becoming exercisable proportionately on each anniversary of the grant date.
Options exercised at $13.75 1,364 shares Employee Stock Option (Right to Buy) into common stock at $13.75 per share on 2026-08-13
Options exercised at $19.00 7,894 shares Employee Stock Option (Right to Buy) into common stock at $19.00 per share on 2026-08-13
Shares sold at $51.4165 1,364 shares Sale of common stock at $51.4165 per share on 2026-08-13
Shares sold at $51.3841 7,894 shares Sale of common stock at $51.3841 per share on 2026-08-13
Indirect 401(K) holdings 811 shares Common stock held indirectly in a 401(K) Plan after the reported transactions
Additional 401(K) shares since prior report 345 shares Shares acquired in the 401(K) account since the last report on 6/9/2025
Option expiration 1 2027-12-31 Expiration date for the 1,364-share employee stock option grant
Option expiration 2 2029-12-31 Expiration date for the 7,894-share employee stock option grant
Employee Stock Option financial
"security_title: Employee Stock Option (Right to Buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
2-for-1 stock split financial
"adjusted to reflect a 2-for-1 stock split on May 21, 2025"
vesting financial
"The option will vest and become exercisable over a period of eight years"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
401(K) Plan financial
"Shares attributed to reporting person's account within issuer's 401(K) Plan"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

FAQ

What transactions did FAST (Fastenal Co) executive Donnalee Papenfuss report on this Form 4?

She reported exercising options for 9,258 shares of Fastenal common stock and selling 9,258 shares on the same date. The filing details strike prices of $13.75 and $19.00, with sale prices around $51.4 per share.

How many FAST (Fastenal Co) shares did Donnalee Papenfuss sell and at what prices?

She reported selling 1,364 shares at $51.4165 and 7,894 shares at $51.3841 per share. These sales followed option exercises into common stock on the same day, according to the Form 4 disclosure.

What option exercise prices did Donnalee Papenfuss disclose for FAST (Fastenal Co) shares?

She exercised employee stock options for 1,364 shares at $13.75 and 7,894 shares at $19.00 per share. The filing notes these were previously reported grants, with one adjusted for a 2-for-1 stock split on May 21, 2025.

Does Donnalee Papenfuss still hold FAST (Fastenal Co) shares after these transactions?

The Form 4 reports 811 Fastenal shares held indirectly in a 401(K) Plan. A footnote explains this amount includes 345 shares acquired in that account since the last report on June 9, 2025.

How do the options reported by Donnalee Papenfuss in FAST (Fastenal Co) vest?

One option grant vests over eight years, with 25% vesting two years after the relevant period and the rest annually. Another vests over five years, with 40% vesting two years after grant and the remainder on each anniversary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Papenfuss Donnalee Kathleen

(Last)(First)(Middle)
2001 THEURER BOULEVARD

(Street)
WINONA MINNESOTA 55987

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
FASTENAL CO [ FAST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP-Strategy and Communication
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/13/2026M1,364A$13.751,364D
Common Stock08/13/2026S1,364D$51.41650D
Common Stock08/13/2026M7,894A$197,894D
Common Stock08/13/2026S7,894D$51.38410D
Common Stock811(1)IHeld in 401(K) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$13.7508/13/2026M1,364 (2)12/31/2027Common Stock1,364$00D
Employee Stock Option (Right to Buy)$19(3)08/13/2026M7,894(3) (4)12/31/2029Common Stcck7,894(3)$00D
Explanation of Responses:
1. Shares attributed to reporting person's account within issuer's 401(K) Plan and includes an additional 345 shares acquired in the account since the last report on 6/9/2025.
2. The option will vest and become exercisable over a period of eight years, with 25% of the option vesting and becoming exercisable two years after the relevant vesting period, and the remainder vesting and becoming exercisable proportionately each year thereafter.
3. The option was previously reported in a Form 3 filing on 11/6/2024 and the amounts reported on this Form 4 are adjusted to reflect a 2-for-1 stock split on May 21, 2025.
4. The option will vest and become exercisable over a period of five years, with 40% of the option vesting and becoming exercisable two years following the date of grant, and the remainder vesting and becoming exercisable proportionately on each anniversary of the grant date.
Remarks:
/s/ John J. Milek, Attorney-in-Fact08/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)